- Citation
- Edmondson SD, Mastracchio A, Mathvink RJ, He J, Harper B, Park YJ, Beconi M, Di Salvo J, Eiermann GJ, He H, Leiting B, Leone JF, Levorse DA, Lyons K, Patel RA, Patel SB, Petrov A, Scapin G, Shang J, Roy RS, Smith A, Wu JK, Xu S, Zhu B, Thornberry NA, Weber AE.: (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem, Volume 49 (12), 2006
- Authors
- Beconi M, Di Salvo J, Edmondson SD, Eiermann GJ, Harper B, He H, He J, Leiting B, Leone JF, Levorse DA, Lyons K, Mastracchio A, Mathvink RJ, Park YJ, Patel RA, Patel SB, Petrov A, Roy RS, Scapin G, Shang J, Smith A, Thornberry NA, Weber AE., Wu JK, Xu S, Zhu B
- Journal
- J Med Chem
- Year
- 2006
- Machine-readable
- REST APIRDF